Recently I wrote a comprehensive email to the Kathy, With in two days I have received a comprehensive and full reply.
The main outline was that DXB announcements were falling flat and not having the normal positive effect on the SP that one associates with Positive News.
Additionally that DXB need to incorporate more into presentations surrounding the Business Investment Opportunity.
In answer to that part of the email Kathy answered below
I value your feedback as a shareholder and echo your understanding of both the scientific and investor communities. We are aware that we must find a balance between the two and as a company still requiring funding from time to time to progress clinical trials, we need to present ourselves more to the investor audience.
The rest of the email answers matters raised with regard to different sectors of the Business.
For me, DXB seems to me to be poised for a serious run up, News and Announcements in the future may well be of a much higher level reflecting the true value of DXB technology.. Broadcast to a new raft of Publishers as well as the well trodden path...
Great to have a response from the Top , Great that their is an appetite for change...
Add to My Watchlist
What is My Watchlist?
